Jing L. Marantz

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Pittsburgh, PA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Ilan Katz, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jing L. Marantz

Form 4 holding Director

Arcturus Therapeutics Holdings Inc.

Security class
Deferred Stock Units
Shares / value
0
Estimated value
$0
Report date
14 Jun 2024
Price
$32.03
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Business Officer

Krystal Biotech, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
205,000
Estimated value
Report date
31 Jan 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding CHIEF MEDICAL OFFICER

Scholar Rock Holding Corp

Security class
Stock Option (Right to Buy)
Shares / value
45,715
Estimated value
Report date
10 Mar 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jing L. Marantz

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .